Publications - Dr. Iman Osman
<< Return to faculty publications page
Publications
| 1. | Bogunovic D; O'Neill DW; Belitskaya-Levy I; Vacic V; Yu YL; Adams S; Darvishian F; Berman R; Shapiro R; Pavlick AC; Lonardi S; Zavadil J; Osman I; Bhardwaj N. "Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival". Proceedings of the National Academy of Sciences of the United States of America. 2009; (#J0181405) |
| 2. | Chen, Ming; Osman, Iman; Orlow, Seth J. "Antifolate activity of pyrimethamine enhances temozolomide-induced cytotoxicity in melanoma cells". Molecular cancer research. 2009; 7: 703 (#J0171596) |
| 3. | Donovan MJ; Osman I; Khan FM; Vengrenyuk Y; Capodieci P; Koscuiszka M; Anand A; Cordon-Cardo C; Costa J; Scher HI. "Androgen receptor expression is associated with prostate cancer-specific survival in castrate patients with metastatic disease". BJU international. 2009; (#J0181406) |
| 4. | Firoz, Elnaz F; Warycha, Melanie; Zakrzewski, Jan; Pollens, Danuta; Wang, Guimin; Shapiro, Richard; Berman, Russell; Pavlick, Anna; Manga, Prashiela; Ostrer, Harry; Celebi, Julide Tok; Kamino, Hideko; Darvishian, Farbod; Rolnitzky, Linda; Goldberg, Judith D; Osman, Iman; Polsky, David. "Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma". Clinical cancer research. 2009; 15: 2573 (#J0180616) |
| 5. | Hatcher D.; Daniels G.; Osman I.; Lee P.. "Molecular mechanisms involving prostate cancer racial disparity". American Journal of Translational Research. 2009; 1: 235 (#J0181192) |
| 6. | Manga P; Goldberg JD; Belitskaya-Levy I; Lobach I; Polsky D; Pavlick A; Shapiro R; Berman R; Osman I; Ostrer H. "Developing genetic markers for melanoma risk assessment [Abstract]". Journal of clinical oncology. 2009; 27: 15S (#J0176403) |
| 7. | O'Reilly, Kathryn E; Warycha, Melanie; Davies, Michael A; Rodrik, Vanessa; Zhou, Xi K; Yee, Herman; Polsky, David; Pavlick, Anna C; Rosen, Neal; Bhardwaj, Nina; Mills, Gordon; Osman, Iman. "Phosphorylated 4E-BP1 is associated with poor survival in melanoma". Clinical cancer research. 2009; 15: 2872 (#J0172046) |
| 8. | Segura MF; Hanniford D; Menendez S; Reavie L; Zou X; Alvarez-Diaz S; Zakrzewski J; Blochin E; Rose A; Bogunovic D; Polsky D; Wei J; Lee P; Belitskaya-Levy I; Bhardwaj N; Osman I; Hernando E. "Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor". Proceedings of the National Academy of Sciences of the United States of America. 2009; 106: 1814 (#J0157867) |
| 9. | Sidash S; Ostrer H; Goldberg JD; Belitskaya-Levy I; Lobach I; Polsky D; Shapiro RL; Berman RS; Osman I; Manga P. "Evaluation of the melanocortin-1-receptor gene in melanoma predisposition, progression and recurrence [Abstract]". Journal of clinical oncology. 2009; 27: 15S (#J0176404) |
| 10. | Wang L.; Zou X.; Berger A.D.; Twiss C.; Peng Y.; Li Y.; Chiu J.; Guo H.; Satagopan J.; Wilton A.; Gerald W.; Basch R.; Wang Z.; Osman I.; Lee P.. "Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA". American Journal of Translational Research. 2009; 1: 62 (#J0175686) |
| 11. | Wang, Guimin; Firoz, Elnaz F; Rose, Amy; Blochin, Elen; Christos, Paul; Pollens, Danuta; Mazumdar, Madhu; Gerald, William; Oddoux, Carole; Lee, Peng; Osman, Iman. "MDM2 Expression and Regulation in Prostate Cancer Racial Disparity". International journal of clinical & experimental pathology. 2009; 2: 353 (#J0157868) |
| 12. | Warycha, M; Kopf, A; Polsky, D; Osman, I. "Changes in the presentation of nodular and superficial spreading melanomas over 35 years [Abstract]". Journal of the American Academy of Dermatology. 2009; 60: AB11 (#J0164451) |
| 13. | Warycha, M; Polsky, D; Osman, I; Mazumdar, M. "Metaanalysis of sentinel lymph node positivity in thin melanoma (<= 1 mm) [Abstract]". Journal of the American Academy of Dermatology. 2009; 60: AB10 (#J0164450) |
| 14. | Warycha, Melanie A; Zakrzewski, Jan; Ni, Quanhong; Shapiro, Richard L; Berman, Russell S; Pavlick, Anna C; Polsky, David; Mazumdar, Madhu; Osman, Iman. "Meta-analysis of sentinel lymph node positivity in thin melanoma (</=1 mm)". Cancer. 2009; 115: 869 (#J0157869) |
| 15. | Wich L.G.; Hamilton H.K.; Shapiro R.L.; Pavlick A.; Berman R.S.; Polsky D.; Goldberg J.D.; Hernando E.; Manga P.; Krogsgaard M.; Kamino H.; Darvishian F.; Lee P.; Orlow S.J.; Oster H.; Bhardwaj N.; Osman I.. "Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research". American Journal of Translational Research. 2009; 1: 35 (#J0175687) |
| 16. | Ye, Huihui; Li, Yirong; Melamed, Jonathan; Pearce, Patrice; Wei, Jianjun; Chiriboga, Luis; Wang, Zhengxin; Osman, Iman; Lee, Peng. "Stromal anti-apoptotic androgen receptor target gene c-FLIP in prostate cancer". Journal of urology. 2009; 181: 872 (#J0157870) |
| 17. | Abbasi, Naheed R; Yancovitz, Molly; Gutkowicz-Krusin, Dina; Panageas, Katherine S; Mihm, Martin C; Googe, Paul; King, Roy; Prieto, Victor; Osman, Iman; Friedman, Robert J; Rigel, Darrell S; Kopf, Alfred W; Polsky, David. "Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma". Archives of dermatology. 2008; 144: 469 (#J0136952) |
| 18. | Bogunovic D; O'Neill D; Adams S; Wang J; Darvishian F; Pavlick AC;0 Shapiro RL; Zavadil J; Osman I; Bhardwaj N. "Gene expression profile for metastatic melanoma and patient survival [Abstract]". Proceedings (American Society of Clinical Oncology). 2008; 26: (#J0139122) |
| 19. | Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P. "Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations". Oncogene. 2008; 27: 3201 (#J0134633) |
| 20. | Dash A; Lee P; Zhou Q; Jean-Gilles J; Taneja S; Satagopan J; Reuter V; Gerald W; Eastham J; Osman I. "Impact of Socioeconomic Factors on Prostate Cancer Outcomes in Black Patients Treated with Surgery". Urology. 2008; 72: 641 (#J0134635) |
| 21. | Doudican, Nicole; Rodriguez, Adrianna; Osman, Iman; Orlow, Seth J. "Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells". Molecular cancer research. 2008; 6: 1308 (#J0148808) |
| 22. | Firoz, EF; Warycha, M; Shapiro, R; Berman, R; Kamino, H; Darvishian, F; Rolnitzky, L; Goldberg, J; Osman, I; Polsky, D. "Polymorphisms of p53 and its negative regulator MDM2 in human melanoma [Abstract]". Journal of investigative dermatology. 2008; 128: S226 (#J0137576) |
| 23. | Freedberg, Daniel E; Rigas, Sushila H; Russak, Julie; Gai, Weiming; Kaplow, Margarita; Osman, Iman; Turner, Faye; Randerson-Moor, Juliette A; Houghton, Alan; Busam, Klaus; Timothy Bishop, D; Bastian, Boris C; Newton-Bishop, Julia A; Polsky, David. "Frequent p16-independent inactivation of p14ARF in human melanoma". Journal of the National Cancer Institute. 2008; 100: 784 (#J0138883) |
| 24. | Han SY; Gai W; Yancovitz M; Osman I; Di Como CJ; Polsky D. "Nucleofection is a highly effective gene transfer technique for human melanoma cell lines". Experimental dermatology. 2008; 17: 405 (#J0135091) |
| 25. | Ng, Bruce; Zakrzewski, Jan; Warycha, Melanie; Christos, Paul J; Bajorin, Dean F; Shapiro, Richard L; Berman, Russell S; Pavlick, Anna C; Polsky, David; Mazumdar, Madhu; Montgomery, Anthony; Liebes, Leonard; Brooks, Peter C; Osman, Iman. "Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients". Clinical cancer research. 2008; 14: 6253 (#J0157873) |
| 26. | Solit, David B; Osman, Iman; Polsky, David; Panageas, Katherine S; Daud, Adil; Goydos, James S; Teitcher, Jerrold; Wolchok, Jedd D; Germino, F Joseph; Krown, Susan E; Coit, Daniel; Rosen, Neal; Chapman, Paul B. "Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma". Clinical cancer research. 2008; 14: 8302 (#J0157871) |
| 27. | Warycha, Melanie A; Christos, Paul J; Mazumdar, Madhu; Darvishian, Farbod; Shapiro, Richard L; Berman, Russell S; Pavlick, Anna C; Kopf, Alfred W; Polsky, David; Osman, Iman. "Changes in the presentation of nodular and superficial spreading melanomas over 35 years". Cancer. 2008; 113: 3341 (#J0157641) |
| 28. | Yu, JZ; Warycha, MA; Christos, PJ; Darvishian, F; Yee, H; Kaminio, H; Berman, RS; Shapiro, RL; Buckley, MT; Liebes, LF; Pavlick, AC; Polsky, D; Brooks, PC; Osman, I. "Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients". Journal of translational medicine. 2008; 6: 127 (#J0159232) |
| 29. | Yu, Jessie Z; Warycha, Melanie A; Christos, Paul J; Darvishian, Farbod; Yee, Herman; Kaminio, Hideko; Berman, Russell S; Shapiro, Richard L; Buckley, Michael T; Liebes, Leonard F; Pavlick, Anna C; Polsky, David; Brooks, Peter C; Osman, Iman. "Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients". Journal of translational medicine. 2008; 6: 70 (#J0157872) |
| 30. | Buckley MT; Yoon J; Yee H; Chiriboga L; Liebes L; Ara G; Qian X; Bajorin DF; Sun TT; Wu XR; Osman I. "The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo". Journal of translational medicine. 2007; 5: 49 (#J0130375) |
| 31. | Ganly, Ian; Talbot, Simon; Carlson, Diane; Viale, Agnes; Maghami, Ellie; Osman, Iman; Sherman, Eric; Pfister, David; Chuai, Shaokun; Shaha, Ashok R; Kraus, Dennis; Shah, Jatin P; Socci, Nicholas D; Singh, Bhuvanesh. "Identification of angiogenesis/metastases genes predicting chemoradiotherapy response in patients with laryngopharyngeal carcinoma". Journal of clinical oncology. 2007; 25: 1369 (#J0163665) |
| 32. | Velazquez, Elsa F; Yancovitz, Molly; Pavlick, Anna; Berman, Russell; Shapiro, Richard; Bogunovic, Dusan; O'Neill, David; Yu, Yi-Lo; Spira, Joanna; Christos, Paul J; Zhou, Xi Kathy; Mazumdar, Madhu; Nanus, David M; Liebes, Leonard; Bhardwaj, Nina; Polsky, David; Osman, Iman. "Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma". Journal of translational medicine. 2007; 5: 2 (#J0131046) |
| 33. | Velazquez, Elsa F; Jungbluth, Achim A; Yancovitz, Molly; Gnjatic, Sacha; Adams, Sylvia; O'Neill, David; Zavilevich, Kira; Albukh, Tatyana; Christos, Paul; Mazumdar, Madhu; Pavlick, Anna; Polsky, David; Shapiro, Richard; Berman, Russell; Spira, Joanna; Busam, Klaus; Osman, Iman; Bhardwaj, Nina. "Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors". Cancer imunity. 2007; 7: 11 (#J0128273) |
| 34. | Yancovitz, Molly; Yoon, Joanne; Mikhail, Maryann; Gai, Weiming; Shapiro, Richard L; Berman, Russell S; Pavlick, Anna C; Chapman, Paul B; Osman, Iman; Polsky, David. "Detection of mutant BRAF alleles in the plasma of patients with metastatic melanoma". Journal of molecular diagnostics. 2007; 9: 178 (#J0126127) |
| 35. | Yancovitz, Molly; Finelt, Nika; Warycha, Melanie A; Christos, Paul J; Mazumdar, Madhu; Shapiro, Richard L; Pavlick, Anna C; Osman, Iman; Polsky, David; Berman, Russell S. "Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma". Cancer. 2007; 110: 1107 (#J0130536) |
| 36. | Andea, A; Osman, I; Scardino, P; Scher, H; Gerald, W. "Mutational profiling of protein kinases in prostate carcinoma [Abstract]". Journal of clinical oncology. 2006; 24: 250S (#J0121896) |
| 37. | Berger, Aaron D; Satagopan, Jaya; Lee, Peng; Taneja, Samir S; Osman, Iman. "Differences in clinicopathologic features of prostate cancer between black and white patients treated in the 1990s and 2000s". Urology. 2006; 67: 120 (#J0119943) |
| 38. | Douglas, D; Zhong, H; Ro, J; Oddoux, C; Pincus, M; Satagopan, J; Gerald, W; Schei, H; Lee, P; Osman, I. "Novel mutations in tyrosine kinase domain of epidermal growth factor receptor in prostate cancer [Abstract]". Journal of clinical oncology. 2006; 24: 244S (#J0121895) |
| 39. | Douglas DA; Zhong H; Ro JY; Oddoux C; Berger AD; Pincus MR; Satagopan JM; Gerald WL; Scher HI; Lee P; Osman I. "Novel mutations of epidermal growth factor receptor in localized prostate cancer". Frontiers in biosciences. 2006; 11: 2518 (#J0114690) |
| 40. | Osman, Iman; Dai, Jie; Mikhail, Maryann; Navarro, Daniel; Taneja, Samir S; Lee, Peng; Christos, Paul; Shen, Ruoqian; Nanus, David M. "Loss of neutral endopeptidase and activation of protein kinase B (Akt) is associated with prostate cancer progression". Cancer. 2006; 107: 2628 (#J0161203) |
| 41. | Osman, Iman; Bajorin, Dean F; Sun, Tung-Tien; Zhong, Hong; Douglas, Diah; Scattergood, Joseph; Zheng, Run; Han, Mark; Marshall, K Wayne; Liew, Choong-Chin. "Novel blood biomarkers of human urinary bladder cancer". Clinical cancer research. 2006; 12: 3374 (#J0120348) |
| 42. | Polsky, D; Mastorides, S; Kim, D; Dudas, M; Leon, L; Leung, D; Woodruff, JM; Brennan, MF; Osman, I; Cordon-Cardo, C. "Altered patterns of RB expression define groups of soft tissue sarcoma patients with distinct biological and clinical behavior". Histology & histopathology. 2006; 21: 743 (#J0114508) |
| 43. | Solit, David B; Garraway, Levi A; Pratilas, Christine A; Sawai, Ayana; Getz, Gad; Basso, Andrea; Ye, Qing; Lobo, Jose M; She, Yuhong; Osman, Iman; Golub, Todd R; Sebolt-Leopold, Judith; Sellers, William R; Rosen, Neal. "BRAF mutation predicts sensitivity to MEK inhibition". Nature. 2006; 439: 358 (#J0120349) |
| 44. | Velazquez, EF; Jungbluth, AA; Osman, I; Yancovitz, M; Adams, S; O'Neill, D; Zavilevich, K; Albukh, T; Pavlick, A; Polsky, D; Shapiro, R; Berman, R; Spira, J; Busam, K; Bhardwaj, N. "Expression of cancer testis (CT) antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM), correlation with prognostic factors and potential role in a melanoma vaccine [Abstract]". Laboratory investigation. 2006; 86: 89A (#J0112158) |
| 45. | Velazquez, EF; Jungbluth, AA; Osman, I; Yancovitz, M; Adams, S; O'Neill, D; Zavilevich, K; Albukh, T; Pavlick, A; Polsky, D; Shapiro, R; Berman, R; Spira, J; Busam, K; Bhardwaj, N. "Expression of cancer testis (CT) antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM), correlation with prognostic factors and potential role in a melanoma vaccine [Abstract]". Modern pathology. 2006; 19: 89A (#J0110543) |
| 46. | Velazquez, EF; Yancovitz, M; Sorhaindo, L; Bogunovic, D; O'Neill, D; Shapiro, R; Pavlick, A; Berman, R; Bhardwaj, N; Spira, J; Christos, P; Nanus, D; Polsky, D; Osman, I. "Neutral endopeptidase (NEP) overexpression is associated with progression in malignant melanoma (MM)and is a potential target of treatment [Abstract]". Laboratory investigation. 2006; 86: 89A (#J0112159) |
| 47. | Velazquez, EF; Yancovitz, M; Sorhaindo, L; Bogunovic, D; O'Neill, D; Shapiro, R; Pavlick, A; Berman, R; Bhardwaj, N; Spira, J; Christos, P; Nanus, D; Polsky, D; Osman, I. "Neutral endopeptidase (NEP) overexpression is associated with progression in malignant melanoma (MM) and is a potential target of treatment [Abstract]". Modern pathology. 2006; 19: 89A (#J0110544) |
| 48. | Yancovitz, M; Velazquez, E; Christos, P; Pavlick, A; Berman, R; Shapiro, R; Bhardwaj, N; Nanus, D; Polsky, D; Osman, I. "Clinical relevance of neutral endopeptidase overexpression in melanoma [Abstract]". Journal of clinical oncology. 2006; 24: 459S (#J0121899) |
| 49. | Hale EK; Stein J; Ben-Porat L; Panageas KS; Eichenbaum MS; Marghoob AA; Osman I; Kopf AW; Polsky D. "Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi-results from the NYU-LCMN registry". British journal of dermatology. 2005; 152: 512 (#J0079327) |
| 50. | Mikhail M; Velazquez E; Shapiro R; Berman R; Pavlick A; Sorhaindo L; Spira J; Mir C; Panageas KS; Polsky D; Osman I. "PTEN expression in melanoma: relationship with patient survival, Bcl-2 expression, and proliferation". Clinical cancer research. 2005; 11: 5153 (#J0105646) |
| 51. | Osman, I; Bajorin, D; Sun, TT; Mikhail, M; Zhong, H; Zheng, R; Han, M; Marshall, W; Liew, CC. "Novel human cancer biomarkers identified by blood cells gene expression [Abstract]". Journal of clinical oncology. 2005; 23: 385S (#J0105604) |
| 52. | Osman, Iman; Mikhail, Maryann; Shuch, Brian; Clute, Megan; Cheli, Carol D; Ghani, Farooq; Thiel, Robert P; Taneja, Samir S. "Serum levels of shed Her2/neu protein in men with prostate cancer correlate with disease progression". Journal of urology. 2005; 174: 2174 (#J0119944) |
| 53. | Abbasi NR; Shaw HM; Rigel DS; Friedman RJ; McCarthy WH; Osman I; Kopf AW; Polsky D. "Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria". JAMA. 2004; 292: 2771 (#J0076214) |
| 54. | Caruso RP; Levinson B; Melamed J; Wieczorek R; Taneja S; Polsky D; Chang C; Zeleniuch-Jacquotte A; Salnikow K; Yee H; Costa M; Osman I. "Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients". Clinical cancer research. 2004; 10: 222 (#J0069631) |
| 55. | Chang DZ; Panageas KS; Osman I; Polsky D; Busam K; Chapman PB. "Clinical significance of BRAF mutations in metastatic melanoma". Journal of translational medicine. 2004; 2: 46 (#J0105647) |
| 56. | Chiriboga L; Osman I; Mikhail M; Lau C. "Tissue microarrays, tread carefully [letter] [comment]". Laboratory investigation. 2004; 84: 1677 (#J0105648) |
| 57. | Osman I; Kang M; Lee A; Deng FM; Polsky D; Mikhail M; Chang C; David DA; Mitra N; Wu XR; Sun TT; Bajorin DF. "Detection of circulating cancer cells expressing uroplakins and epidermal growth factor receptor in bladder cancer patients". International journal of cancer. 2004; 111: 934 (#J0068848) |
| 58. | Osman I; Crawford M; Jordan F; Young A; Norman J; Thomson A. "Expression and localization of cell adhesion molecules in human fetal membranes during parturition". Journal of reproductive immunology. 2004; 63: 11 (#J0069699) |
| 59. | Osman I; Yee H; Taneja SS; Levinson B; Zeleniuch-Jacquotte A; Chang C; Nobert C; Nanus DM. "Neutral endopeptidase protein expression and prognosis in localized prostate cancer". Clinical cancer research. 2004; 10: 4096 (#J0069700) |
| 60. | Osman, I; Shuch, B; Yee, H; Lee, P; Cordon-Crado, C; Taneja, S; Chang, C; Satagopan, J. "Racial disparity of epidermal growth factor receptor (EGFR) expression in prostate cancer (PC) [Abstract]". Journal of clinical oncology. 2004; 22: 395S (#J0077967) |
| 61. | Polsky, D; Freedberg, D; Russak, J; Kaplow, M; Busam, K; Osman, I. "Frequent alteration of the p161NK4A tumor suppressor gene by deletion, promotoer methylation, and point mutation in human melanoma metastases [Abstract]". Journal of investigative dermatology. 2004; 122: A159 (#J0073006) |
| 62. | Shuch B; Mikhail M; Satagopan J; Lee P; Yee H; Chang C; Cordon-Cardo C; Taneja SS; Osman I. "Racial disparity of epidermal growth factor receptor expression in prostate cancer". Journal of clinical oncology. 2004; 22: 4673 (#J0074493) |
| 63. | Drobnjak M; Melamed J; Taneja S; Melzer K; Wieczorek R; Levinson B; Zeleniuch-Jacquotte A; Polsky D; Ferrara J; Perez-Soler R; Cordon-Cardo C; Pagano M; Osman I. "Altered expression of p27 and Skp2 proteins in prostate cancer of African-American patients". Clinical cancer research. 2003; 9: 2613 (#J0051916) |
| 64. | Gorden A; Osman I; Gai W; He D; Huang W; Davidson A; Houghton AN; Busam K; Polsky D. "Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues". Cancer research. 2003; 63: 3955 (#J0051915) |
| 65. | Hazan C; Melzer K; Panageas KS; Li E; Kamino H; Kopf A; Cordon-Cardo C; Osman I; Polsky D. "Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma". Cancer. 2002; 95: 634 (#J0053883) |
| 66. | Morris MJ; Akhurst T; Osman I; Nunez R; Macapinlac H; Siedlecki K; Verbel D; Schwartz L; Larson SM; Scher HI. "Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer". Urology. 2002; 59: 913 (#J0052214) |
| 67. | Morris, Michael J; Reuter, Victor E; Kelly, W Kevin; Slovin, Susan F; Kenneson, Kate; Verbel, David; Osman, Iman; Scher, Howard I. "HER-2 profiling and targeting in prostate carcinoma". Cancer. 2002; 94: 980 (#J0120350) |
| 68. | Nunez R; Macapinlac HA; Yeung HW; Akhurst T; Cai S; Osman I; Gonen M; Riedel E; Scher HI; Larson SM. "Combined 18F-FDG and 11C-methionine PET scans in patients with newly progressive metastatic prostate cancer". Journal of nuclear medicine. 2002; 43: 46 (#J0052215) |
| 69. | Osman I; Sherman E; Singh B; Venkatraman E; Zelefsky M; Bosl G; Scher H; Shah J; Shaha A; Kraus D; Cordon-Cardo C; Pfister DG. "Alteration of p53 pathway in squamous cell carcinoma of the head and neck: impact on treatment outcome in patients treated with larynx preservation intent". Journal of clinical oncology. 2002; 20: 2980 (#J0051898) |
| 70. | Polsky D; Melzer K; Hazan C; Panageas KS; Busam K; Drobnjak M; Kamino H; Spira JG; Kopf AW; Houghton A; Cordon-Cardo C; Osman I. "HDM2 protein overexpression and prognosis in primary malignant melanoma". Journal of the National Cancer Institute. 2002; 94: 1803 (#J0053426) |
| 71. | Osman, I; Polsky, D; Melzer, K; Hazan, C; Cordon-Cardo, C; Houghton, A; Busam, K; Bastian, B. "HDM2 protein overexpression: a potential target of treatment of cutaneous melanoma [Abstract]". Clinical cancer research. 2001; 7: 3790S (#J0098994) |
| 72. | Osman I; Scher HI; Drobnjak M; Verbel D; Morris M; Agus D; Ross JS; Cordon-Cardo C. "HER-2/neu (p185neu) protein expression in the natural or treated history of prostate cancer". Clinical cancer research. 2001; 7: 2643 (#J0051899) |
| 73. | Polsky D; Bastian BC; Hazan C; Melzer K; Pack J; Houghton A; Busam K; Cordon-Cardo C; Osman I. "HDM2 protein overexpression, but not gene amplification, is related to tumorigenesis of cutaneous melanoma". Cancer research. 2001; 61: 7642 (#J0028853) |
| 74. | Drobnjak M; Osman I; Scher HI; Fazzari M; Cordon-Cardo C. "Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone". Clinical cancer research. 2000; 6: 1891 (#J0051900) |
| 75. | Kelly WK; Osman I; Reuter VE; Curley T; Heston WD; Nanus DM; Scher HI. "The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer". Clinical cancer research. 2000; 6: 838 (#J0051901) |
| 76. | Ghossein RA; Osman I; Bhattacharya S; Ferrara J; Fazzari M; Cordon-Cardo C; Scher HI. "Detection of prostatic specific membrane antigen messenger RNA using immunobead reverse transcriptase polymerase chain reaction". Diagnostic molecular pathology. 1999; 8: 59 (#J0051903) |
| 77. | Lee CT; Capodieci P; Osman I; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C. "Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer". Clinical cancer research. 1999; 5: 977 (#J0051905) |
| 78. | Macapinlac HA; Humm JL; Akhurst T; Osman I; Pentlow K; Shangde C; Yeung HW; Squire O; Finn RD; Scher HI; Larson SM. "Differential Metabolism and Pharmacokinetics of L-[1-(11)C]-Methionine and 2-[(18)F] Fluoro-2-deoxy-D-glucose (FDG) in Androgen Independent Prostate Cancer". Clinical positron imaging. 1999; 2: 173 (#J0051891) |
| 79. | Osman I; Drobnjak M; Fazzari M; Ferrara J; Scher HI; Cordon-Cardo C. "Inactivation of the p53 pathway in prostate cancer: impact on tumor progression". Clinical cancer research. 1999; 5: 2082 (#J0051904) |
| 80. | Cordon-Cardo C; Koff A; Drobnjak M; Capodieci P; Osman I; Millard SS; Gaudin PB; Fazzari M; Zhang ZF; Massague J; Scher HI. "Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma". Journal of the National Cancer Institute. 1998; 90: 1284 (#J0051908) |
| 81. | Wu RL; Osman I; Wu XR; Lu ML; Zhang ZF; Liang FX; Hamza R; Scher H; Cordon-Cardo C; Sun TT. "Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: alternative pathways of bladder epithelial differentiation and tumor formation [published erratum appears in Cancer Res 1998 Jul 1;58(13):2904]". Cancer research. 1998; 58: 1291 (#J0003273) |
| 82. | Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C. "Alterations affecting the p53 control pathway in bilharzial-related bladder cancer". Clinical cancer research. 1997; 3: 531 (#J0051906) |
| 83. | Osman I; Scher H; Dalbagni G; Reuter V; Zhang ZF; Cordon-Cardo C. "Chromosome 16 in primary prostate cancer: a microsatellite analysis". International journal of cancer. 1997; 71: 580 (#J0051909) |
| 84. | Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C. "Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer". Clinical cancer research. 1997; 3: 2247 (#J0051907) |
| 85. | Osman I; Hamza R; El-Khodary A; Khaled H; Gaafer R; El-Zawahry H. "A randomized study of recombinant colony stimulating factor as adjuvant to induction treatment of aggressive non-Hodgkin lymphoma". Journal of the Egyptian National Cancer Institute. 1994; 7: 115 (#J0051911) |
| 86. | Osman I; Hamza R; El-Khodary A; Khaled H; Gaafer R; Kamel H; El-Zawahry H. "The efficacy and tolerability of tropistron in the prevention of chemotherapy induced emesis". Journal of the Egyptian National Cancer Institute. 1993; 6: 249 (#J0051910) |
All data from NYU School of Medicine Ehrman Medical Library Faculty Bibliography
NYU Faculty may edit their publications and access other personalized services at http://myinfo.med.nyu.edu
For more information contact: facbib@library.med.nyu.edu
or see: http://library.med.nyu.edu/library/eresources/faculty/bib-faq.html
